scholarly article | Q13442814 |
P50 | author | Kathleen E. Sullivan | Q44832717 |
P2093 | author name string | K McDonald | |
D McDonald-McGinn | |||
E Zackai | |||
E Luning Prak | |||
R Zemble | |||
P2860 | cites work | Role of TBX1 in human del22q11.2 syndrome | Q24298685 |
Partial V(D)J recombination activity leads to Omenn syndrome | Q24336454 | ||
The Philadelphia story: the 22q11.2 deletion: report on 250 patients | Q28140691 | ||
Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice | Q28204189 | ||
DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1 | Q28204282 | ||
Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways | Q28511687 | ||
Timed mutation and cell-fate mapping reveal reiterated roles of Tbx1 during embryogenesis, and a crucial function during segmentation of the pharyngeal system via regulation of endoderm expansion | Q28512256 | ||
TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome | Q28512803 | ||
Tbx1 expression in pharyngeal epithelia is necessary for pharyngeal arch artery development | Q28589109 | ||
Sensitization (IgE antibody) to food allergens in wheezing infants and children | Q30464423 | ||
Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis | Q33595849 | ||
Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) | Q33655443 | ||
Monosomy 22 with humoral immunodeficiency: is there an immunoglobulin chain deficit? | Q33670194 | ||
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study | Q33679532 | ||
Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells | Q33700550 | ||
Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. | Q33977505 | ||
Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. | Q34415690 | ||
Maintaining the norm: T-cell homeostasis | Q34770383 | ||
A population study of chromosome 22q11 deletions in infancy | Q35261188 | ||
Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease | Q35568601 | ||
Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome | Q35571176 | ||
T cell homeostasis in tolerance and immunity | Q36128016 | ||
The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments | Q36291877 | ||
Diversification, not use, of the immunoglobulin VH gene repertoire is restricted in DiGeorge syndrome | Q36362304 | ||
Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells | Q36369770 | ||
Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands | Q36671094 | ||
Cytokines and T-cell homeostasis | Q36791437 | ||
Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. | Q37095109 | ||
IL-7 is critical for homeostatic proliferation and survival of naive T cells | Q37113213 | ||
T-cell receptor analysis in Omenn's syndrome: evidence for defects in gene rearrangement and assembly | Q77720696 | ||
A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery | Q80564566 | ||
Prevention of spontaneous arthritis by inhibiting homeostatic expansion of autoreactive CD4+ T cells in the K/BxN mouse model | Q82424450 | ||
Natural IgE production in the absence of MHC Class II cognate help | Q82872924 | ||
Hypogammaglobulinaemia in DiGeorge sequence | Q93528862 | ||
T cell homeostasis. | Q37117568 | ||
Omenn syndrome: inflammation in leaky severe combined immunodeficiency | Q37321176 | ||
Homeostasis of naive and memory T cells | Q37356053 | ||
Homeostatic proliferation and survival of naïve and memory T cells | Q37564251 | ||
Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations | Q38476363 | ||
The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome | Q39518283 | ||
CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia. | Q39626063 | ||
Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome | Q39806773 | ||
Humoral immunity in DiGeorge syndrome | Q40461047 | ||
The spectrum of the DiGeorge syndrome | Q41635874 | ||
Impaired thymic output and restricted T-cell repertoire in two infants with immunodeficiency and early-onset generalized dermatitis. | Q42695173 | ||
Selective polysaccharide antibody deficiency in familial DiGeorge syndrome | Q43797757 | ||
Prediction of persistent immunodeficiency in the DiGeorge anomaly | Q43937212 | ||
Induction of T helper type 2 immunity by a point mutation in the LAT adaptor | Q44029002 | ||
A LAT mutation that inhibits T cell development yet induces lymphoproliferation | Q44029004 | ||
Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). | Q44540762 | ||
Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome. | Q44895166 | ||
In vivo longitudinal analysis of a dominant TCR repertoire selected in human response to influenza virus | Q45762273 | ||
T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome | Q47587653 | ||
Early development of immunity in diGeorge syndrome. | Q47824766 | ||
Mutations in TBX1 genocopy the 22q11.2 deletion and duplication syndromes: a new susceptibility factor for mental retardation. | Q51905604 | ||
Clinical features of 78 adults with 22q11 Deletion Syndrome. | Q51925287 | ||
The EUROclass trial: defining subgroups in common variable immunodeficiency. | Q51971194 | ||
Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. | Q51985343 | ||
B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. | Q51993431 | ||
Maintenance of serological memory by polyclonal activation of human memory B cells. | Q52008907 | ||
Presenting phenotype in 100 children with the 22q11 deletion syndrome. | Q52085444 | ||
Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). | Q52106652 | ||
Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2. | Q52212966 | ||
Long-term assessment of T-cell populations in DiGeorge syndrome | Q57996345 | ||
T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome | Q58193933 | ||
Velocardiofacial Syndrome | Q58857442 | ||
Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome) | Q61714879 | ||
Post-Natal Ontogenesis of the T-Cell Receptor CD4 and CD8 Vβ Repertoire and Immune Function in Children with DiGeorge Syndrome | Q61714885 | ||
Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease | Q62111763 | ||
Graves' disease in patients with 22q11.2 deletion | Q62111826 | ||
The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder | Q69255215 | ||
CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition | Q71047892 | ||
The pathology of Omenn's syndrome | Q71126303 | ||
Clinical and immunologic spectrum of the DiGeorge syndrome | Q72093326 | ||
Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome | Q73590802 | ||
DiGeorge syndrome with Graves' disease: A case report | Q73793467 | ||
B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients | Q74114699 | ||
Homeostatic expansion occurs independently of costimulatory signals | Q77136906 | ||
Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease | Q77678228 | ||
P433 | issue | 3 | |
P304 | page(s) | 409-418 | |
P577 | publication date | 2010-05-15 | |
P1433 | published in | Clinical Immunology | Q15752921 |
P1476 | title | Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) | |
P478 | volume | 136 |
Q36988231 | 22q11.2 deletion syndrome |
Q52642064 | A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis? |
Q51168850 | A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (digeorge syndrome/velocardiofacial syndrome). |
Q41151666 | Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma. |
Q99711424 | Autoimmune Thyroid Disease in Specific Genetic Syndromes in Childhood and Adolescence |
Q48636789 | Autoimmunity associated with chemically induced thymic dysplasia |
Q91923337 | Candidate modifier genes for immune function in 22q11.2 deletion syndrome |
Q41452524 | Clinical Phenotype of DiGeorge Syndrome with Negative Genetic Tests: A Case of DiGeorge-Like Syndrome? |
Q37705233 | Clinical predictors of autoimmune and severe atopic disease in pediatric heart transplant recipients. |
Q34786042 | Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor |
Q32182385 | Graves' Disease in Pediatric and Elderly Patients with 22q11.2 Deletion Syndrome. |
Q37921180 | Head and neck manifestations of 22q11.2 deletion syndromes. |
Q36257777 | Immune Dysfunction in Children with CHARGE Syndrome: A Cross-Sectional Study |
Q39206354 | Immunodeficiencies Associated with Abnormal Newborn Screening for T Cell and B Cell Lymphopenia |
Q37943798 | Immunological aspects of 22q11.2 deletion syndrome |
Q48273912 | Increased Levels of Interferon-Inducible Protein 10 (IP-10) in 22q11.2 Deletion Syndrome |
Q47140966 | Modulating Neuroinflammation to Treat Neuropsychiatric Disorders |
Q37947135 | New frontiers in primary immunodeficiency disorders: immunology and beyond…. |
Q30278478 | Patterns of Allergic Sensitization in High IgE Syndromes |
Q37108404 | Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome |
Q89966092 | The Genetics and Epigenetics of 22q11.2 Deletion Syndrome |
Q52765219 | The immune deficiency of chromosome 22q11.2 deletion syndrome. |
Q37234148 | Transgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes including Mzb1. |
Q30244646 | Variability in Clinical and Anatomical Manifestation of Velocardiofacial Syndrome Presents Diagnostic and Policy Uncertainty |
Q52713279 | Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome. |
Q90154352 | Vitamin D status and the immune assessment in 22q11.2 deletion syndrome |
Search more.